United Kingdom - Amazon Inc (NASDAQ: AMZN) has started entering the global CBD market. The giant online retailer has started selling CBD products, but only as a trial, with the retailer calling it a pilot program.
The pilot program is run for UK customers only, with a select few retailers. Commenting on the story, Amazon said it is "always trying to increase the selection we provide to customers." The pilot was conducted by invitation to select retailers, with the company requiring careful screening to ensure the listed products comply with government regulations for the sale of CBD.
The pilot project apparently began during the summer, but further details were not provided before.
Furthermore, the originally American company Amazon quickly indicated that any form of hemp that can be absorbed on the platform is prohibited for sellers, except for those participating in the pilot project, which is accessible by invitation only. There is talk of about ten manufacturers selected to list their products, including the UK-known brands Healthspan and Natures Aid.
The list of products containing CBD in the UK follows recent regulatory developments targeting the cannabinoid in the country.
Regulators in the UK have indicated that they consider the cannabinoid a dietary supplement and that it wants to develop a well-regulated industry for it.
In an effort to bring the CBD market into line, the UK Food Standards Agency has set a deadline of March 2021 for companies to have their products tested and validated by the authorities in order to remain on the market. Products without a validated application for a Novel Food authorization will be removed from the shelves from April 1.